Edition:
United Kingdom

Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

71.27USD
16 Nov 2018
Change (% chg)

$2.83 (+4.14%)
Prev Close
$68.44
Open
$67.90
Day's High
$71.75
Day's Low
$66.70
Volume
203,557
Avg. Vol
118,853
52-wk High
$71.75
52-wk Low
$37.08

Select another date:

Tue, Aug 28 2018

Emergent BioSolutions to buy Narcan maker Adapt Pharma

Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment.

UPDATE 2-Emergent BioSolutions to buy Narcan maker Adapt Pharma

* Adapt partner Opiant soars in after-hours trading (Adds details and comment from conference call)

Emergent BioSolutions to buy Adapt Pharma for up to $735 mln

Aug 28 Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma for up to $735 million to acquire its drug Narcan, the only needle-free emergency treatment approved to treat opioid overdose.

Select another date: